Skip to main content

Advertisement

Table 3 Frequently reported treatment-emergent adverse events

From: Factors influencing treatment outcome in patients with gastroesophageal reflux disease: outcome of a prospective pragmatic trial in Asian patients

MedDRA preferred term Asia (N = 210), n (%) Rest of the world (N = 1718), n (%)
Diarrhea 11 (5.2) 47 (2.7)
Upper respiratory tract infection 7 (3.3) 8 (0.5)
Nasopharyngitis 6 (2.9) 10 (0.6)
Headache 3 (1.4) 69 (4.0)
Vomiting 3 (1.4) 10 (0.6)
Constipation 2 (1.0) 18 (1.0)
Heart rate increased 2 (1.0) 0 (0.0)
Insomnia 2 (1.0) 13 (0.8)
Nausea 0 (0.0) 33 (1.9)
Abdominal pain 1 (0.5) 22 (1.3)
Influenza 0 (0.0) 19 (1.1)
  1. A comparison of Asian populations with the rest of the world (intent-to-treat population, N = 210).